Metraipolis › archive › dc_69e367a1edc8

Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial — Europe PMC PMID:42315639

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42315639
DOI
10.1007/s00259-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-19T08:07:24.298Z
SHA-256 of the archived text
302355b15ca34fb087bc03ced40598c397302e8ac9e3ba7f1221e5ef11ce2651
Stable URL of this page
https://metraipolis.com/documento/dc_69e367a1edc8

How to cite

Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial — Europe PMC PMID:42315639 — Europe PMC (en), https://europepmc.org/article/MED/42315639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69e367a1edc8 (Metraipolis archive dc_69e367a1edc8, sha256 302355b15ca34fb087bc03ced40598c397302e8ac9e3ba7f1221e5ef11ce2651)
BibTeX
@misc{dc69e367a1edc8,
  title = {Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial — Europe PMC PMID:42315639},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42315639},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69e367a1edc8; sha256 302355b15ca34fb087bc03ced40598c397302e8ac9e3ba7f1221e5ef11ce2651},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42315639. Agents can read the archived copy with the MCP tool read_document.